BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lehman HL, Kidacki M, Warrick JI, Stairs DB. NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation. Oncotarget 2018;9:11180-96. [PMID: 29541406 DOI: 10.18632/oncotarget.24358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shaverdashvili K, Padlo J, Weinblatt D, Jia Y, Jiang W, Rao D, Laczkó D, Whelan KA, Lynch JP, Muir AB, Katz JP. KLF4 activates NFκB signaling and esophageal epithelial inflammation via the Rho-related GTP-binding protein RHOF. PLoS One 2019;14:e0215746. [PMID: 30998758 DOI: 10.1371/journal.pone.0215746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Elango R, Vishnubalaji R, Shaath H, Alajez NM. Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition. Cancer Cell Int 2021;21:515. [PMID: 34565361 DOI: 10.1186/s12935-021-02213-2] [Reference Citation Analysis]
3 Cui L, Xu F, Wang M, Li L, Qiao T, Cui H, Li Z, Sun C. Dietary natural astaxanthin at an early stage inhibits N-nitrosomethylbenzylamine-induced esophageal cancer oxidative stress and inflammation via downregulation of NFκB and COX2 in F344 rats. Onco Targets Ther 2019;12:5087-96. [PMID: 31308688 DOI: 10.2147/OTT.S197044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
4 Crosas-Molist E, Samain R, Kohlhammer L, Orgaz J, George S, Maiques O, Barcelo J, Sanz-Moreno V. RhoGTPase Signalling in Cancer Progression and Dissemination. Physiol Rev 2021. [PMID: 34541899 DOI: 10.1152/physrev.00045.2020] [Reference Citation Analysis]
5 Ding X, Wang X, Lu S, Gao X, Ju S. P120-Catenin And Its Phosphorylation On Tyr228 Inhibits Proliferation And Invasion In Colon Adenocarcinoma Cells. Onco Targets Ther 2019;12:10213-25. [PMID: 32063714 DOI: 10.2147/OTT.S211973] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Landmesser ME, Raup-Konsavage WM, Lehman HL, Stairs DB. Loss of p120ctn causes EGFR-targeted therapy resistance and failure. PLoS One 2020;15:e0241299. [PMID: 33112928 DOI: 10.1371/journal.pone.0241299] [Reference Citation Analysis]
7 Nienhüser H, Wirsik N, Schmidt T. Esophageal Tumor Microenvironment. Adv Exp Med Biol 2020;1296:103-16. [PMID: 34185288 DOI: 10.1007/978-3-030-59038-3_6] [Reference Citation Analysis]
8 Lehman HL, Kidacki M, Stairs DB. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes. Sci Rep 2020;10:18829. [PMID: 33139779 DOI: 10.1038/s41598-020-75866-0] [Reference Citation Analysis]
9 Cao L, Wang X, Zhu G, Li S, Wang H, Wu J, Lu T, Li J. Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review. Integr Cancer Ther 2021;20:15347354211061720. [PMID: 34825600 DOI: 10.1177/15347354211061720] [Reference Citation Analysis]
10 Tao J, Zhao H, Xie X, Luo M, Gao Z, Sun H, Huang Z. The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma. Onco Targets Ther 2019;12:471-8. [PMID: 30666126 DOI: 10.2147/OTT.S193206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]